Study in Portuguese hospitals to describe patient characteristics, treatment patterns and outcomes

Trial Identifier: D3250R00088
Sponsor: AstraZeneca
Start Date: August 2021
Primary Completion Date: November 2022
Study Completion Date: November 2022

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Portugal Amadora, Portugal, 2720-276
Portugal Barcelos, Portugal, 4750-275
Portugal Coimbra, Portugal, 3000 -076
Portugal Faro, Portugal, 8000-368
Portugal Leiria, Portugal, 2410-197
Portugal Lisboa, Portugal, 1649-035
Portugal Matosinhos, Portugal, 4464-513
Portugal Portimão, Portugal, 8500-338
Portugal Porto, Portugal, 4200 - 319
Portugal Porto, Portugal, 4200-319
Portugal Santarém, Portugal, 2005-177
Portugal Vila Nova de Gaia, Portugal, 4430 - 999
Portugal Vila Real, Portugal, 5000-508